Sandbox
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 06-02-2024
AUM:
₹ 508.73 Cr
Expense Ratio
2.38%
Benchmark
BSE Healthcare TRI
ISIN
INF03VN01878
Minimum Investment
500.0
Minimum Topup
500.0
Minimum SIP Amount
100
Fund Manager
Ramesh Mantri
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth | 4.29 | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
13.562
Last change
-0.13 (-0.9733%)
Fund Size (AUM)
₹ 508.73 Cr
Performance
16.55% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Ramesh Mantri
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.91 |
| JB Chemicals & Pharmaceuticals Limited | 8.38 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.9 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 5.44 |
| FORTIS HEALTHCARE LIMITED. EQ | 5.25 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.79 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 4.5 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 3.9 |
| Clearing Corporation of India Ltd | 3.77 |
| ALKEM LABORATORIES LIMITED EQ | 2.76 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 89.47 |
| Chemicals | 2.11 |
| Capital Goods | 2.07 |